Triple helix formation with pyrimidine deoxyoligonucleotides for the sequence-specific recognition of DNA duplex targets suffers from a decrease in affinity as the pH of the medium increases to that of physiological fluids. A solution to this problem has been identified and entails the substitution of N'6-methyl-8-oxo-2'-deoxyadenosine (M) for the 5-methyl-deoxycytosine base residues. The triple helix forming ability of an oligonudeotide consisting of thymidine and M residues is pH independent in the physiological range. Furthermore, M has been found to be superior to the previously used 5-methyldeoxycytidine and deoxyguanosine in conferring increased affinity for duplex DNA under physiological salt conditions.
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In recent years the development of methodologies for the sequence-specific recognition and chemical modification of DNA have created the opportunity to modulate gene expression in vivo (1) (2) (3) . The most promising, currently available technology for the sequence-specific recognition of DNA is triple helix formation via Hoogsteen hydrogen bond interactions within T-A-T and C+-G-C triplets. Although the formation of triple helical RNA structures in homopolymers has been known for over three decades (4, 5) , this phenomenon has only recently been exploited for the recognition of mixed sequences by deoxyoligonucleotides (6) . Such triplestranded interactions have been used to inhibit the binding of transcription factors and restriction endonucleases to their DNA targets (7) .
A severe limitation of this recognition motif is the strong pH dependence of triple strand formation (8) . This pH dependence is due to the requirement that the N3 of cytidine, of the third strand, be protonated in order to form the C+*G-C triplet (Fig. 1A) (9) . Thus, the binding of a mixed polypurine duplex utilizing deoxycytidine-and thymidine-containing oligonucleotides requires conditions considerably more acidic than the intracellular pH range of 7.1-7.6 (6).
Three approaches have been attempted to circumvent this shortcoming. The first involved the substitution of 5-methyldeoxycytidine for deoxycytidine, a strategy based upon the fact that homopolymers of 5-methyldeoxycytidine and deoxyguanosine can form triple-stranded structures at neutral pH under certain, nonphysiological, salt conditions (10) . This observation has been extended to the recognition of mixed sequences (11) . The second approach taken was the substitution of deoxyguanosine for deoxycytidine (12) (13) (14) , to yield an alternative binding motif in which the third strand binds in an antiparallel orientation with respect to the purine strand of the duplex (Fig. 1B) . However, this latter modification pertains only to DNA targets containing a relatively large proportion of G-C base pairs. Recently, a third approach has involved the use of a pseudoisocytidine derivative that contains the appropriate pattern of hydrogen bond donors in a neutral species (15) .
An evaluation of the first two methodologies has led us to the conclusion that the 5-methyldeoxycytidine and deoxyguanosine substitution schemes only marginally enhance binding under physiological salt and pH conditions. Therefore, we searched for a neutral heterocyclic mimetic of protonated cytosine that would enable the synthesis of oligomers having enhanced specific affinity for duplex DNA under conditions that mimic the intracellular environment.
The conversion of a deoxyguanosine residue into an 8-oxodeoxyguanosine residue is accompanied by a GC to T-A mutation upon replication in Escherichia coli (16) . The explanation offered was that the introduction of the keto group in the 8-position forces the deoxyguanosine residue to adopt a syn conformation such that the N7 proton and the 06 mimic the base-pairing face of thymidine. Since 8-substituted adenosine analogs are known to exist predominantly in the syn conformation (17) , we reasoned that an 8-oxodeoxyadenosine derivative could behave as a mimetic of the protonated deoxycytidine species implicated in triplex formation. The hydrogens present on the 6-amino group and the N7 of 8-oxodeoxyadenosine would take the place of the two hydrogens located on the 4-amino group and N3 of the protonated deoxycytidine residue as shown in Fig. 1C .
MATERIALS AND METHODS
Synthesis of M Synthon. The synthesis of compound 3 was based upon the methodology reported by Ikehara and Kaneko (18) as shown in Fig. 2 .
A solution of 20 g of N6-methyl-2'-deoxyadenosine (19) in 300 ml of water containing 15 g of sodium acetate was treated with 500 ml of saturated bromine water. After 6 hr of stirring at room temperature, the mixture was stored at 4°C for 10 hr. The pH was then adjusted to 7 with 2 M sodium hydroxide and sodium bisulfite was added to the stirred suspension until it became light yellow in color. The mixture was heated until a clear solution was obtained and then allowed to cool. After the mixture had been kept at 4°C for 18 hr, the precipitate was collected by filtration to afford 13.7 g of solid (51%).
Nineteen grams of material obtained by this method was suspended in 150 ml of acetic anhydride containing 19 g of sodium acetate. The mixture was kept at 130°C for 48 hr and then poured onto 600 cm3 of crushed ice. The mixture was treated with 600 ml of ethyl acetate and allowed to stir for 6 hr. The biphasic mixture was filtered through a fritted glass filter, and the layers were separated. The organic layer was washed with water, saturated sodium bicarbonate solution, and brine. The organic solution was filtered through a 10-cm-wide by a 4-cm-deep silica gel bed, and the bed was Abbreviation: M, N6-methyl-8-oxo-2'-deoxyadenosine.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. washed with 500 ml of ethyl acetate. The combined filtrates were evaporated and coevaporated three times with 100-ml portions of methanol. The residue was dissolved in 100 ml of a 1 M sodium methoxide solution in methanol, and the mixture was kept at room temperature for 96 hr. After this time, the pH was adjusted to 7 with acetic acid and the solution was evaporated. The residue was chromatographed on a silica gel column using methylene chloride/methanol, 4:1 (vol/vol), containing 2.5% triethylamine. The productcontaining fractions were evaporated, and the residue was crystallized from ethanol to afford 3.1 g of product (18%). mp 182-1840C; 1H NMR(dimethyl sulfoxide-d6): 10.27 (bs, 1H, H-7), 8.09 (s, 1H, H-2), 6.49 (q, 1H, H-N6), 6 .14 (dd, 1H, J1',2'a = J1',2'b = 6.6 Hz), 5.17 Oligonucleotides. Oligonucleotides were synthesized using H-phosphonate methodology (20) and purified by denaturing acrylamide gel electrophoresis followed by Sephadex G-25 gel filtration. A key feature to note is that the N6 exocyclic amine of M does not require protection for oligonucleotide synthesis as assessed by nucleoside composition analysis of the resulting deoxyoligonucleotides (21) . The nucleoside composition of each of the oligomers was confirmed by digestion of the oligomers to nucleosides and analysis by reverse-phase HPLC. The oligomers were converted to nucleosides by incubating 1 OD of oligomer with 3 units of P1 nuclease and 2 units of calf intestinal alkaline phosphatase (Boehringer Mannheim) in 30 mM NaOAc, pH 5.2/1 mM ZnSO4 overnight at 37°C. The digested material was then injected directly onto a C18 column (Amicon, 100-A pores), and the nucleosides were separated by an acetonitrile gradient buffered with 50 mM potassium phosphate (pH 4.2).
DNA Duplex Target. The duplex DNA target used was the 259-base-pair Pst I-Xma I fragment of the HER2 promoter labeled at the 3' end of the purine-rich strand by filling in the Xma I site with [a-32P]dCTP and Klenow fragment (22) . Footprint. Enzymatic footprinting was carried out by treatment of the hybridization mixtures with 1 unit of DNase I at 370C for 1 min. To ensure reproducible digestion patterns, 1 ,.g of salmon sperm DNA was added to each reaction mixture just prior to the addition of the DNase I. The reactions were then terminated by the addition of 20 mM EDTA and placing the mixture on ice. The samples were precipitated with 1 ,ug of carrier tRNA, 0.3 M sodium acetate, and 2 volumes of ethanol, washed with 70% ethanol, and vacuum evaporated. The samples were resuspended in 80% formamide containing dyes and heated to 950C for 5 min prior to loading. Digestion products were analyzed by 5% denaturing polyacrylamide gel electrophoresis and visualized by autoradiography.
RESULTS AND DISCUSSION
To test the hypothesis that an 8-oxo-2'-deoxyadenosine could behave as a protonated deoxycytidine analog the nucleoside analog 3 (M) was substituted for 5-methyldeoxycytidine residues in triple helix-forming oligonucleotides.
The DNA duplex target chosen was the promoter region of HER2, a protooncogene implicated in human breast and ovarian cancers (22) . The 15-nucleotide-long sequences shown in Fig. 3 were synthesized and their binding was assessed by DNA footprinting using DNase I digestion (23) . The presence of the bound third strand inhibits digestion by DNase I.
Buffer conditions were selected to approximate known intracellular pH and mono-and multivalent cation concentrations (24, 25) . We performed the footprint experiment at pH 7.2 and 37°C in the presence of 1 mM spermine, 140 mM KCl, 10 mM NaCl, and 1 mM MgCl2 in 20 mM Mops with the results shown in Fig. 4 . Under these conditions, oligomer A, with M substitution, afforded partial protection at 1 ,uM and full protection at 10 ,uM. Neither the control oligomer B nor the antiparallel deoxyguanosine-substituted oligomer C gave a partial footprint at 10 ,uM. It should be noted that Beal and Dervan (13) reported that an iron-EDTA-derivatized G-and T-containing 19-mer could efficiently cleave a target sequence at a concentration of 0.5 ,uM, whereas we do not observe any protection with oligomer C. This difference in affinities could be due to several factors, including the difference in length, effect of context and the ratio of G-C to A*T base pairs comprising the binding site, and different mono-and divalent cation concentrations used in the assay.
We also tested the effect of the incorporation of M on the specificity of binding of oligomers to their target sequences. Sequence D, with a single M for thymidine mismatch, shows no footprint at 10 ,M. We conclude that the M-G-C interaction is highly specific. The above experiment was repeated at pH 6.4 using oligomers A and B. Under these conditions, oligomers A and B afford a footprint with full protection at 10 ,uM (Fig. 5) . The footprint experiment was also repeated at pH 7.6, where the M-substituted oligomer A again afforded a full footprint at 10 ,M (Fig. 5) , thus demonstrating the pH independence of binding of M-containing oligomers within the intracellular pH range.
CONCLUSION
These studies led to the conclusion that M-substituted oligomers are superior to 5-methyldeoxycytidine-substituted oligomers in this sequence in regard to duplex DNA binding Target Sequence: affinity under intracellular salt and pH conditions. The complete substitution ofthe 5-methyldeoxycytidine residues with M confers pH independence of binding for an oligonucleotide, within the physiological pH range, without compromising its specificity. Furthermore, M is easily synthesized and does not require exocyclic amino group protection during oligonucleotide synthesis. We have also demonstrated that, for the HER2 target sequence, the parallel motif incorporating M has better binding properties compared to the antiparallel motif under physiological pH and salt conditions. We have employed M in the construction of oligomers for the inhibition of transcription elongation in an in vitro'system (27) . Thus, M-containing deoxyoligonucleotides have significant promise in the development of therapeutic agents based upon triple helix formation in vivo.
